🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Cleveland Clinic Children’s #Peds GI representing our institution and our speciality, at NASPGHAN #NASPGHAN2024, so incredibly well! #futureisbright #FutureLeaders Jacob Kurowski Sophia A. Patel MD Jessica Barry Rasha Abou Jaoudeh, MD Aditi Mittal Mira Younis, MD

Repeatedly, ⬆️ antiTNF levels = ✅Response in Peds IBD

Title says it all - Jeremy Adler, MD, MSc Sandra Kim MD Early tumour necrosis factor antagonist treatment prevents perianal fistula development in children with Crohn’s disease: post hoc analysis of the RISK study gut.bmj.com/content/early/…

🔥🔥News from #WeTheFibrosisLab🔬 #STARConsortium🔥🔥Thank you Gastroenterology for highlighting our work on the role of creeping fat derived free fatty acids on stricturing Crohn's disease gastrojournal.org/article/S0016-…. Check it out. A thread 🧵 (1/7) Miguel Regueiro Joseph Sleiman, MD, FACP

Tune in March 12 – LIVE from Cleveland Clinic: CHRONIC GI DISEASES – Transitioning Peds Patient to Adult Care. Join Jessica Philpott Claire Beveridge, MD Jacob Kurowski Stephen Lupe Cleveland Clinic MD for this CME MOC event.  Register bit.ly/LIVECC2025

U.S. FDA approves TREMFYA® (guselkumab), the first and only IL-23 inhibitor offering both subcutaneous and intravenous induction options, for adult patients with moderately to severely active Crohn’s disease #Crohns #guselkumab jnj.com/media-center/p…

📊 In real-world data from 44 children with mild-mod #Crohns, 8-week azithromycin + metronidazole led to 64% remission—82% remained in remission at 16 weeks. A promising alternative to EEN/steroids. #IBD 🔗 onlinelibrary.wiley.com/doi/10.1002/jp…

Dr. Rupa Banerjee’s luggage did not make it to San Diego, but her Wisdom and Knowledge did. #DDW2025 AIG IBD group is making a difference in south East Asia for patients with IBD She reports on the survey results from 100000 individuals across 104 villages. Incidence increases

Less than 3 weeks, sign up straight away!

Florian Rieder promising phase 2a STENOVA interim results TGFb receptor antagonist, AGMB129, in symptomatic >/= 1 TI stricture. 👉TGF-b major pro-fibrotic growth factor. ➡️ mean 17.5 yrs CD, fcal 373, SESCD7 ➡️sig ⬇️ fibrotic &inflamm pathway ➡️improved stricture passability

A huge volume of work & success led by Florian Rieder !

Excited to see this important work out in IBDJournal & CC360 from our Stanford Childrens Center for IBD & Celiac Disease team that uncovers new potential avenues to advance wellness in youth with IBD through self compassion!

Very excited to share a comprehensive (150+ page) new resource for caregivers/ families of children living with IBD and/or autoimmune liver disease. This Caregiver Coping resource addresses a broad array of common concerns and questions, from navigating diagnosis, to managing

Last week - 4th Peds IBD Symposium thanks2 Kaplan Foundation. Amazing talks by Thaddeus Stappenbeck, MD, PhD on new frontiers in wound repair, Sandra Kim MD, Emily Geist PhD, Diana Schnee RD on RW diet implementation, & Alan Moss CSO Crohn's & Colitis Foundation on prevent IBD trials w/ diet & meds!